QQ客服 官方微博 反馈留言

	The Efficacy and Safety of Nivolumab, Pembrolizumab, and Atezolizumab in Treatment of Advanced Non-small Cell Lung Cancer
	Chen, Rui; Tao, Yuquan; Xu, Xin; Shan, Liang; Jiang, Hongyuan; Yin, Qilei; Pei, Lingyan; Cai, Feng; Ma, Lifang; Yu, Yongchun
刊名	DISCOVERY MEDICINE
	2018
卷号	26期号:143
ISSN号	1539-6509
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3632721
专题	上海中医药大学
推荐引用方式 GB/T 7714	Chen, Rui,Tao, Yuquan,Xu, Xin,et al. The Efficacy and Safety of Nivolumab, Pembrolizumab, and Atezolizumab in Treatment of Advanced Non-small Cell Lung Cancer[J]. DISCOVERY MEDICINE,2018,26(143).
APA	Chen, Rui.,Tao, Yuquan.,Xu, Xin.,Shan, Liang.,Jiang, Hongyuan.,...&Yu, Yongchun.(2018).The Efficacy and Safety of Nivolumab, Pembrolizumab, and Atezolizumab in Treatment of Advanced Non-small Cell Lung Cancer.DISCOVERY MEDICINE,26(143).
MLA	Chen, Rui,et al."The Efficacy and Safety of Nivolumab, Pembrolizumab, and Atezolizumab in Treatment of Advanced Non-small Cell Lung Cancer".DISCOVERY MEDICINE 26.143(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。